Authors:
Rotterud, R
Berner, A
Holm, R
Skovlund, E
Fossa, SD
Citation: R. Rotterud et al., p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder, BJU INT, 88(3), 2001, pp. 202-208
Authors:
Holm, R
Mullertz, A
Christensen, E
Hoy, CE
Kristensen, HG
Citation: R. Holm et al., Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats, EUR J PH SC, 14(4), 2001, pp. 331-337
Authors:
Holm, R
Mullertz, A
Pedersen, GP
Kristensen, HG
Citation: R. Holm et al., Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids, PHARM RES, 18(9), 2001, pp. 1299-1304
Authors:
Holm, R
Skovlund, E
Skomedal, H
Florenes, VA
Tanum, G
Citation: R. Holm et al., Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas, HISTOPATHOL, 39(1), 2001, pp. 43-49
Authors:
Florenes, VA
Maelandsmo, GM
Faye, R
Nesland, JM
Holm, R
Citation: Va. Florenes et al., Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome, J PATHOLOGY, 195(5), 2001, pp. 530-536
Authors:
Florenes, VA
Faye, RS
Maelandsmo, GM
Nesland, JM
Holm, R
Citation: Va. Florenes et al., Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma, CLIN CANC R, 6(9), 2000, pp. 3614-3620
Authors:
De Jonge, ETM
Lindeque, BG
Burger, W
Nesland, JM
Holm, R
Citation: Etm. De Jonge et al., Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?, INT J GYN C, 10(2), 2000, pp. 137-142
Authors:
Janco, M
Sykora, D
Svec, F
Frechet, JMJ
Schweer, J
Holm, R
Citation: M. Janco et al., Rapid determination of molecular parameters of synthetic polymers by precipitation/redissolution high-performance liquid chromatography using "molded" monolithic column, J POL SC PC, 38(15), 2000, pp. 2767-2778
Authors:
Baekelandt, M
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: M. Baekelandt et al., Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer, J CL ONCOL, 18(22), 2000, pp. 3775-3781
Authors:
Baekelandt, MM
Holm, R
Nesland, JM
Trope, CG
Kristensen, GB
Citation: Mm. Baekelandt et al., P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer, ANTICANC R, 20(2B), 2000, pp. 1061-1067
Authors:
Helland, A
Kraggerud, SM
Kristensen, GB
Holm, R
Abeler, VM
Huebner, K
Borresen-Dale, AL
Lothe, RA
Citation: A. Helland et al., Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival, INT J CANC, 88(2), 2000, pp. 217-222
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study, CLIN CANC R, 5(10), 1999, pp. 2848-2853
Authors:
de Jonge, ETM
Viljoen, E
Lindeque, BG
Amant, F
Nesland, JM
Holm, R
Citation: Etm. De Jonge et al., The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy, INT J GYN C, 9(3), 1999, pp. 198-205
Authors:
Reed, W
Florenes, VA
Holm, R
Hannisdal, E
Nesland, JM
Citation: W. Reed et al., Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients, VIRCHOWS AR, 435(2), 1999, pp. 116-124
Authors:
Baekelandt, M
Holm, R
Trope, CG
Nesland, JM
Kristensen, GB
Citation: M. Baekelandt et al., The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer, ANN ONCOL, 10(11), 1999, pp. 1335-1341
Authors:
Baekelandt, M
Kristensen, GB
Nesland, JM
Trope, CG
Holm, R
Citation: M. Baekelandt et al., Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer, J CL ONCOL, 17(7), 1999, pp. 2061-2068
Authors:
Hennig, EM
Kvinnsland, S
Holm, R
Nesland, JM
Citation: Em. Hennig et al., Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas, ACTA ONCOL, 38(7), 1999, pp. 931-938
Authors:
Hennig, EM
Suo, ZH
Karlsen, F
Holm, R
Thoresen, S
Nesland, JM
Citation: Em. Hennig et al., HPV positive bronchopulmonary carcinomas in women with previous high-gradecervical intraepithelial neoplasia (CIN III), ACTA ONCOL, 38(5), 1999, pp. 639-647
Authors:
Lie, AK
Skarsvag, S
Skomedal, H
Haugen, OA
Holm, R
Citation: Ak. Lie et al., Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection, INT J GYN P, 18(1), 1999, pp. 5-11
Authors:
Baekelandt, M
Kristensen, GB
Trope, CG
Nesland, JM
Holm, R
Citation: M. Baekelandt et al., Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer, ANTICANC R, 19(5C), 1999, pp. 4469-4474
Authors:
Hennig, EM
Suo, ZH
Thoresen, S
Holm, R
Kvinnsland, S
Nesland, JM
Citation: Em. Hennig et al., Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III)., BREAST CANC, 53(2), 1999, pp. 121-135
Authors:
Skomedal, H
Kristensen, GB
Lie, AK
Holm, R
Citation: H. Skomedal et al., Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21,p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas, GYNECOL ONC, 73(2), 1999, pp. 223-228